Fabrication and characterization of anti-rosacea 3D nanofibrous customized sheet masks as a novel scaffold for repurposed use of spironolactone with pre-clinical …
NA Elhesaisy, SA Swidan, RA Tawfiq… - International Journal of …, 2023 - Elsevier
The repurposed oral use of spironolactone (SP) as an anti-rosacea drug faces many
challenges that hinder its efficacy and compliance. In this study, a topically applied …
challenges that hinder its efficacy and compliance. In this study, a topically applied …
Fabrication and characterization of anti-rosacea 3D nanofibrous customized sheet masks as a novel scaffold for repurposed use of spironolactone with pre-clinical …
NA Elhesaisy, SA Swidan, RA Tawfiq… - International Journal …, 2023 - europepmc.org
The repurposed oral use of spironolactone (SP) as an anti-rosacea drug faces many
challenges that hinder its efficacy and compliance. In this study, a topically applied …
challenges that hinder its efficacy and compliance. In this study, a topically applied …
Fabrication and characterization of anti-rosacea 3D nanofibrous customized sheet masks as a novel scaffold for repurposed use of spironolactone with pre-clinical …
NA Elhesaisy, SA Swidan, RA Tawfiq… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
The repurposed oral use of spironolactone (SP) as an anti-rosacea drug faces many
challenges that hinder its efficacy and compliance. In this study, a topically applied …
challenges that hinder its efficacy and compliance. In this study, a topically applied …